EBANGA
Live / Applied — Statement of use — registration review complete (as of 01 Apr 2026)
What this means for you
Not registered yet, but its 13 Jun 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98599610
- Mark type
- Stylized text
- Filed
- 13 Jun 2024
- Published for opposition
- 04 Feb 2025
- Attorney of record
- Eric J. Shimanoff
Goods and services
- Class 005 — Pharmaceuticals: Human antibody-based pharmaceutical for treatment and prophylaxis for Ebola Virus Disease
- Class 044 — Medical, beauty and agricultural services: Medical services, namely, treatment and prophylaxis for Ebola Virus Disease using human antibodies
Owner
- Ridgeback Biotherapeutics L.P., Coconut Grove, FL, US
- Ridgeback Biotherapeutics L.P., Coconut Grove, FL, US
Prosecution history
- 01 Apr 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 01 Apr 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 31 Mar 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 31 Mar 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 31 Mar 2026 — ASSIGNED TO LIE
- 25 Mar 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 16 Mar 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 16 Mar 2026 — NON-FINAL ACTION E-MAILED
- 16 Mar 2026 — SU - NON-FINAL ACTION - WRITTEN
- 11 Mar 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 03 Sept 2025 — USE AMENDMENT FILED
- 10 Mar 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 03 Sept 2025 — TEAS STATEMENT OF USE RECEIVED
- 01 Apr 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 04 Feb 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED